Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.
Methanex Corporation ( NASDAQ: MEOH) Q4 2024 Earnings Conference Call January 30, 2025 11:00 AM ET Sarah Herriott – Director-Investor Relations Rich Sumner – President and Chief Executive Officer ...